Gaurav Shah

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

RCKT

Current role

CEO, Board Member

2018-01-01–present

1 call Latest call 2021-08-09

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Executive Officer	$671,076	—	$806,751	$1,613,377	$403,048	$15,988	$3,510,241
2024	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Executive Officer	$635,880	—	$1,997,976	$4,001,997	$190,764	$14,790	$6,841,407
2023	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Executive Officer	$625,000	—	$2,330,993	$4,668,994	$375,000	$13,566	$8,013,553
2022	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Executive Officer	$598,333	—	$1,814,989	$3,684,991	$434,390	$20,500	$6,553,203
2021	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Executive Officer	$590,000	—	—	$6,998,550	$318,600	$11,600	$7,918,750
2020	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Executive Officer	$540,000	$486,000	—	$5,821,735	—	$11,400	$6,859,135
2019	Rocket Pharmaceuticals, Inc. (RCKT)	Chief Executive Officer	$480,000	$349,140	—	$3,043,306	—	$11,200	$3,883,646
2018	Rocket Pharmaceuticals, Inc. (RCKT)	M.D. Chief Executive Officer	$413,735	$300,940	—	$5,651,220	—	$9,857	$6,375,752

Earnings-call appearances and filed executive appointments or departures, newest first.